An analogue of the C-terminal heptapeptide of cholecystokinin (CCK) r(
SO3-)-Nle-Gly-D-Trp-Nle-Asp-a-2-phenylethylester is a potent, specific
CCK receptor antagonist. Intraperitoneal injection of the antagonist
abolished suppression of real feeding and sham feeding by exogenous CC
K-8 (1.8 nmol/kg), and significantly increased real feeding. Assuming
an antagonist distribution like that of exogenous CCK-8, our results s
uggest that exogenous CCK-8 and endogenous CCK reduce food intake by a
cting at a site(s) accessible to peripherally administered peptides.